当前位置:首页 - 行情中心 - 中国医药(600056) - 财务分析

中国医药

(600056)

  

流通市值:152.82亿  总市值:152.88亿
流通股本:14.95亿   总股本:14.96亿

中国医药(600056)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润2.27亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益1433931.53万元,未分配利润779253.93万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产3569105.59万元,负债2135174.06万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入8,262,744,582.7534,148,359,638.9926,099,729,998.417,797,322,228.73
营业总成本7,973,445,487.2832,983,445,215.4225,216,783,611.9917,153,291,092.83
营业利润304,650,879.12931,567,858.53850,564,674.59606,652,720.96
利润总额304,613,642.69953,188,513.89842,783,779604,023,833.45
净利润227,200,028.63686,623,882.02620,917,976.67449,756,770.46
其他综合收益884,977.29-362,481.48-3,545,260.38-1,457,158.88
综合收益总额228,085,005.92686,261,400.54617,372,716.29448,299,611.58
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计26,788,148,856.2926,370,732,716.9328,878,917,996.9828,691,822,636.82
非流动资产合计8,902,906,995.768,910,326,196.618,998,958,623.378,927,573,413.33
资产总计35,691,055,852.0535,281,058,913.5437,877,876,620.3537,619,396,050.15
流动负债合计17,223,758,138.3817,176,763,537.4519,912,131,853.4319,292,800,192.75
非流动负债合计4,127,982,443.793,993,465,112.133,876,990,851.764,357,850,134.22
负债合计21,351,740,582.1721,170,228,649.5823,789,122,705.1923,650,650,326.97
归属于母公司股东权益合计11,987,780,202.6111,820,515,989.311,657,211,823.4411,569,791,063.03
股东权益合计14,339,315,269.8814,110,830,263.9614,088,753,915.1613,968,745,723.18
负债和股东权益合计35,691,055,852.0535,281,058,913.5437,877,876,620.3537,619,396,050.15
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计7,438,600,455.4236,243,984,709.6826,583,177,927.7617,583,177,308.75
经营活动现金流出小计8,920,176,697.8435,238,554,160.0626,903,604,540.1518,269,315,032.28
经营活动产生的现金流量净额-1,481,576,242.421,005,430,549.62-320,426,612.39-686,137,723.53
投资活动现金流入小计8,187,430.1943,843,014.211,514,517.12144,083.19
投资活动现金流出小计65,496,987.21411,499,628.29281,151,821.22200,157,179.81
投资活动产生的现金流量净额-57,309,557.02-367,656,614.08-279,637,304.1-200,013,096.62
筹资活动现金流入小计1,475,926,683.576,492,003,159.824,208,007,673.323,215,720,287.81
筹资活动现金流出小计1,429,227,227.676,750,237,069.634,581,509,564.692,994,248,643.97
筹资活动产生的现金流量净额46,699,455.9-258,233,909.81-373,501,891.37221,471,643.84
汇率变动对现金及现金等价物的影响-842,648.331,779,865.311,887,281.63321,865.34
现金及现金等价物净增加额-1,493,028,991.87381,319,891.04-971,678,526.23-664,357,310.97
期末现金及现金等价物余额2,218,549,837.943,711,578,829.812,358,580,412.542,665,901,627.8
TOP↑